Abvc Biopharma ABVC
NASDAQ ABVC
$1.02 -0.04 (-3.77%)
At close: Oct 1, 2026 · 4:00 PM EDT

Abvc Biopharma (ABVC) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Abvc Biopharma (ABVC) posted Depreciation & Amortization (CF) of $12,299 for Q2 2026, up 83.6% from $6,697 a year earlier and up 112.7% from the prior quarter.

Analysis

Abvc Biopharma (ABVC) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Abvc Biopharma was $49,203, down 6.8% year-over-year; for FY2025, it came in at $25,330, down 20.9% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of -7.4% (FY2020 to FY2025).
  • In prior years, Abvc Biopharma's Depreciation & Amortization (CF) was $32,025 in FY2024 (+12.2%), $28,531 in FY2023 (+19.9%), $23,799 in FY2022 (+98.4%) and $11,993 in FY2021 (-67.7%).
  • Quarterly Depreciation & Amortization (CF) has run from a low of $1,286 in Q1 2024 to a high of $28,627 in Q3 2024 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) increased in four of the last eight quarters, with growth averaging 90.9%.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q1 2025, with growth of 446.0%; the weakest was Q1 2024, with a decline of 80.2%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $5,783 (Q1 2026), $5,791 (Q4 2025) and $25,330 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Abvc Biopharma 27.31 Mn 29.30 Mn - 12,299.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12,299.00
Mar 31, 2026 5,783.00
Dec 31, 2025 5,791.00
Sep 30, 2025 25,330.00
Jun 30, 2025 6,697.00
Mar 31, 2025 7,021.00
Dec 31, 2024 10,420.00
Sep 30, 2024 28,627.00
Jun 30, 2024 13,305.00
Mar 31, 2024 1,286.00
Dec 31, 2023 7,582.00
Sep 30, 2023 7,459.00
Jun 30, 2023 6,997.00
Mar 31, 2023 6,493.00
Dec 31, 2022 6,435.00
Sep 30, 2022 6,462.00
Jun 30, 2022 5,491.00
Mar 31, 2022 5,411.00
Dec 31, 2021 3,268.00
Sep 30, 2021 2,856.00
API Access

Abvc Biopharma Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ABVC&period=max&api_key=YOUR_API_KEY